EUVIMEDEUVIMED entdecken
Crossref

Lessons learned: endoscopy with 96-hour ambulatory esophageal pH monitoring as a tool to avoid proton pump inhibitor use in cancer patients with refractory gastroesophageal reflux

George Triadafilopoulos iD

Diseases of the Esophagus · 2025

DOI: 10.1093/dote/doaf102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diseases of the Esophagus, 2025. Verfasst von George Triadafilopoulos. Beteiligte Einrichtung: Department of Gastroenterology, Hepatology and Nutrition, UT MD Anderson Cancer Center, Houston TX, USA. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Gastroesophageal Reflux, Esophageal pH Monitoring, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The proton pump inhibitors (PPIs) are extensively prescribed for the empirical treatment of epigastric pain and heartburn in cancer patients. However, they carry the potential for drug interactions with antineoplastic agents during active cancer therapy, and osteopenia, opportunistic infections, adverse cardiovascular outcomes, and altered gut microbiome in long-term users in survivorship. Herein, we examined the use of endoscopy with esophageal 96-hour ambulatory pH monitoring in guiding clinicians in safely prescribing PPI in 21 such patients. We retrospectively studied patients with active cancer or in survivorship, presenting with PPI-refractory heartburn. All underwent an endoscopy with esophageal ambulatory pH monitoring performed “off” PPI therapy for 96 hours, following a “liberal diet” for the first 48, and a “restrictive diet” for the latter 48 hours. Acid exposure time (AET) ≥ 6% per 24 hours was defined as abnormal. For each patient, the average AET from the first 2 days was considered as baseline and was compared with that from the latter 2 days (on restrictive diet). We concluded that ambulatory 96-hour pH monitoring, identifies 48% of patients with normal AET, who may not need PPI. Esophageal pH monitoring on restrictive diet normalizes AET in 73% of patients, thereby allowing esophageal acid control to be achieved with diet alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsGastroesophageal RefluxEsophageal pH MonitoringNeoplasmsHeartburnEsophagoscopyHumansMaleFemaleRetrospective StudiesMiddle AgedAgedAdult

Stichwörter der Autor:innen

ambulatory esophageal pH monitoringcancerdrug–drug interactionsgastroesophageal reflux diseaseproton pump inhibitors

Substanzen

Proton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Gastroenterology, Hepatology and Nutrition, UT MD Anderson Cancer Center, Houston TX, USA.

ORCID-Profile: George Triadafilopoulos

Zitieren

APA

Triadafilopoulos, G. (2025). Lessons learned: endoscopy with 96-hour ambulatory esophageal pH monitoring as a tool to avoid proton pump inhibitor use in cancer patients with refractory gastroesophageal reflux. Diseases of the Esophagus. https://doi.org/10.1093/dote/doaf102

Vancouver

Triadafilopoulos G. Lessons learned: endoscopy with 96-hour ambulatory esophageal pH monitoring as a tool to avoid proton pump inhibitor use in cancer patients with refractory gastroesophageal reflux. Diseases of the Esophagus. 2025. doi:10.1093/dote/doaf102

BibTeX
@article{Triadafilopoulos2025,
  author = {Triadafilopoulos, George},
  title = {Lessons learned: endoscopy with 96-hour ambulatory esophageal pH monitoring as a tool to avoid proton pump inhibitor use in cancer patients with refractory gastroesophageal reflux},
  journal = {Diseases of the Esophagus},
  year = {2025},
  doi = {10.1093/dote/doaf102}
}
Kostenlos starten →